Medical Journals

Enhanced Priming of Adaptive Immunity by a Proapoptotic Mutant of Mycobacterium Tuberculosis.

Authors:
  • Hinchey Joseph
  • Lee Sunhee
  • Jeon Bo Y
  • Basaraba Randall J
  • Venkataswamy Manjunatha M
  • Chen Bing
  • Chan John
  • Braunstein Miriam
  • Orme Ian M
  • Derrick Steven C
  • Morris Sheldon L
  • Jacobs William R
  • Porcelli Steven A

From: Department of Microbiology and Immunology and Howard Hughes Medical Institute, Albert Einstein College of Medicine, New York, New York 10461, USA.

The Journal of clinical investigation

  • Publish Date: Aug 2007
  • ISSN: 0021-9738
  • Volume: 117
  • Issue: 8
  • Pages: 2279-88
  • Medium: Print
  • Language: English
  • Citation (JAMA): Hinchey Joseph, Lee Sunhee, Jeon Bo Y, et al. Enhanced Priming of Adaptive Immunity by a Proapoptotic Mutant of Mycobacterium Tuberculosis.. J. Clin. Invest. Aug 2007;117:2279-88

Abstract

The inhibition of apoptosis of infected host cells is a well-known but poorly understood function of pathogenic mycobacteria. We show that inactivation of the secA2 gene in Mycobacterium tuberculosis, which encodes a component of a virulence-associated protein secretion system, enhanced the apoptosis of infected macrophages by diminishing secretion of mycobacterial superoxide dismutase. Deletion of secA2 markedly increased priming of antigen-specific CD8(+) T cells in vivo, and vaccination of mice and guinea pigs with a secA2 mutant significantly increased resistance to M. tuberculosis challenge compared with standard M. bovis bacille Calmette-GuĂ©rin vaccination. Our results define a mechanism for a key immune evasion strategy of M. tuberculosis and provide what we believe to be a novel approach for improving mycobacterial vaccines.

Mesh Headings (Keywords): Adenosine Triphosphatases, Animals, Bacterial Proteins, Cell Line, Gene Deletion, Guinea Pigs, Humans, Macrophages, Membrane Transport Proteins, Mice, Mice, Inbred BALB C, Mycobacterium bovis, Mycobacterium tuberculosis, Superoxide Dismutase, Tuberculosis, Tuberculosis Vaccines


Check for Full Text / PubMed Unique Identifier (PMID): 17671656


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.